Last week, the Senate Finance Committee held a hearing focused on drug prices where the discussion was filled with misleading claims. We agree too many Americans struggle to afford their medicines, but we must take a holistic approach to addressing the problem. Focusing solely on drug prices and relying on misleading claims will not fix the affordability challenges patients worry about most.
